{
    "Symbol": "INCY",
    "AssetType": "Common Stock",
    "Name": "Incyte Corporation",
    "Description": "Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.",
    "CIK": "879169",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH",
    "Address": "1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "16492720000",
    "EBITDA": "665348000",
    "PERatio": "48.76",
    "PEGRatio": "0.466",
    "BookValue": "19.62",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "1.51",
    "RevenuePerShareTTM": "15.29",
    "ProfitMargin": "0.1",
    "OperatingMarginTTM": "0.175",
    "ReturnOnAssetsTTM": "0.069",
    "ReturnOnEquityTTM": "0.0837",
    "RevenueTTM": "3394635000",
    "GrossProfitTTM": "1593729000",
    "DilutedEPSTTM": "1.51",
    "QuarterlyEarningsGrowthYOY": "-0.952",
    "QuarterlyRevenueGrowthYOY": "0.074",
    "AnalystTargetPrice": "89.38",
    "TrailingPE": "48.76",
    "ForwardPE": "14.95",
    "PriceToSalesRatioTTM": "5.49",
    "PriceToBookRatio": "3.823",
    "EVToRevenue": "3.896",
    "EVToEBITDA": "18.63",
    "Beta": "0.737",
    "52WeekHigh": "86.29",
    "52WeekLow": "65.07",
    "50DayMovingAverage": "79.47",
    "200DayMovingAverage": "76.09",
    "SharesOutstanding": "222965000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}